[go: up one dir, main page]

DK173883D0 - Substituerede 8-phenylxanthiner - Google Patents

Substituerede 8-phenylxanthiner

Info

Publication number
DK173883D0
DK173883D0 DK1738/83A DK173883A DK173883D0 DK 173883 D0 DK173883 D0 DK 173883D0 DK 1738/83 A DK1738/83 A DK 1738/83A DK 173883 A DK173883 A DK 173883A DK 173883 D0 DK173883 D0 DK 173883D0
Authority
DK
Denmark
Prior art keywords
phenylxanthines
substituted
bronchodilators
preparation
methods
Prior art date
Application number
DK1738/83A
Other languages
English (en)
Other versions
DK173883A (da
Inventor
James A Bristol
Edward W Badger
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of DK173883D0 publication Critical patent/DK173883D0/da
Publication of DK173883A publication Critical patent/DK173883A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK173883A 1982-04-21 1983-04-20 Substituerede 8-phenylxanthiner DK173883A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37064982 1982-04-21
US06/370,649 US4452788A (en) 1982-04-21 1982-04-21 Substituted 8-phenylxanthines

Publications (2)

Publication Number Publication Date
DK173883D0 true DK173883D0 (da) 1983-04-20
DK173883A DK173883A (da) 1983-10-22

Family

ID=23460567

Family Applications (1)

Application Number Title Priority Date Filing Date
DK173883A DK173883A (da) 1982-04-21 1983-04-20 Substituerede 8-phenylxanthiner

Country Status (7)

Country Link
US (1) US4452788A (da)
EP (1) EP0092398B1 (da)
JP (1) JPS58189181A (da)
AT (1) ATE26115T1 (da)
DE (1) DE3370482D1 (da)
DK (1) DK173883A (da)
GR (1) GR78575B (da)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4593095A (en) * 1983-02-18 1986-06-03 The Johns Hopkins University Xanthine derivatives
US4769377A (en) * 1983-02-18 1988-09-06 The Johns Hopkins University Adenosine receptor antagonists
DE3324115A1 (de) * 1983-07-05 1985-01-17 Dr. Karl Thomae Gmbh, 7950 Biberach Neue imidazole, ihre herstellung und diese verbindungen enthaltende arzneimittel
DE3347290A1 (de) * 1983-12-28 1985-07-11 Dr. Karl Thomae Gmbh, 7950 Biberach Neue 2-phenyl-imidazole, ihre herstellung und diese verbindungen enthaltende arzneimittel
US4612315A (en) * 1984-10-26 1986-09-16 The United States Of America As Represented By The Department Of Health And Human Services Biologically-active 1,3-dipropyl-8-phenylxanthine derivatives
US4696932A (en) * 1984-10-26 1987-09-29 The United States Of America As Represented By The Department Of Health And Human Services Biologically-active xanthine derivatives
GB8510758D0 (en) 1985-04-27 1985-06-05 Wellcome Found Compounds
JPS62208295A (ja) * 1986-03-07 1987-09-12 Nippon Kayaku Co Ltd ヒポキサンチン塩基を有する新規化合物およびその製造法
US4772607A (en) * 1986-05-20 1988-09-20 Warner-Lambert Company Dialkenyl derivatives of xanthine, pharmaceutical compositions and methods of use therefor
US4755517A (en) * 1986-07-31 1988-07-05 Warner-Lambert Company Derivatives of xanthine, pharmaceutical compositions and methods of use therefor
AT388500B (de) * 1987-10-27 1989-06-26 Wellcome Found Antivirale 8-phenylxanthine
US5298508A (en) * 1988-07-19 1994-03-29 The United States Of America As Represented By The Department Of Health And Human Services Irreversible inhibitors of adenosine receptors
FR2659656B1 (fr) * 1990-03-15 1994-09-09 Sanofi Sa Derives de pyrimidinedione-2,4 et medicaments les contenant.
US5208240A (en) * 1991-03-12 1993-05-04 Merrell Dow Pharmaceuticals Inc. 8-substituted purines as selective adenosine receptor agents
US5484920A (en) * 1992-04-08 1996-01-16 Kyowa Hakko Kogyo Co., Ltd. Therapeutic agent for Parkinson's disease
TW252044B (da) * 1992-08-10 1995-07-21 Boehringer Ingelheim Kg
JP2613355B2 (ja) * 1992-09-28 1997-05-28 協和醗酵工業株式会社 パーキンソン氏病治療剤
CA2112031A1 (en) * 1992-12-24 1994-06-25 Fumio Suzuki Xanthine derivatives
US5661153A (en) * 1994-07-19 1997-08-26 Japan Energy Corporation 1-arylpyrimidine derivatives and pharmaceutical use thereof
US6545002B1 (en) 1999-06-01 2003-04-08 University Of Virginia Patent Foundation Substituted 8-phenylxanthines useful as antagonists of A2B adenosine receptors
US7317017B2 (en) 2002-11-08 2008-01-08 Cv Therapeutics, Inc. A2B adenosine receptor antagonists
US7125993B2 (en) * 2001-11-09 2006-10-24 Cv Therapeutics, Inc. A2B adenosine receptor antagonists
HU229504B1 (hu) 2001-11-09 2014-01-28 Gilead Sciences A2B-adenozinreceptor-antagonisták
US20080318983A1 (en) * 2001-11-09 2008-12-25 Rao Kalla A2b adenosine receptor antagonists
US6977300B2 (en) * 2001-11-09 2005-12-20 Cv Therapeutics, Inc. A2B adenosine receptor antagonists
ES2208063B1 (es) * 2002-04-01 2005-10-01 Almirall Prodesfarma, S.A. Nuevos derivados de la 4-(pirrolopirimidin-6-il)bencenosulfonamida.
ES2387653T3 (es) * 2004-09-01 2012-09-27 Gilead Sciences, Inc. Procedimiento de cicatrización de heridas utilizando antagonistas del receptor de adenosina A2B
US20070059740A1 (en) * 2005-08-26 2007-03-15 Linden Joel M Method of targeting a2b adenosine receptor antagonist therapy
US8193200B2 (en) * 2007-01-04 2012-06-05 University Of Virginia Patent Foundation Antagonists of A2B adenosine receptors for treatment of inflammatory bowel disease

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2840559A (en) * 1954-06-22 1958-06-24 Krantz Jr Nuclearly substituted 8-theophyllines and method of making the same
GB982079A (en) * 1962-05-01 1965-02-03 Dresden Arzneimittel Process for the production of xanthine derivatives
FR5878M (da) * 1966-07-27 1968-03-18

Also Published As

Publication number Publication date
DE3370482D1 (en) 1987-04-30
DK173883A (da) 1983-10-22
ATE26115T1 (de) 1987-04-15
EP0092398B1 (en) 1987-03-25
US4452788A (en) 1984-06-05
EP0092398A1 (en) 1983-10-26
GR78575B (da) 1984-09-27
JPS58189181A (ja) 1983-11-04

Similar Documents

Publication Publication Date Title
DK173883D0 (da) Substituerede 8-phenylxanthiner
ES520985A0 (es) Procedimiento para la preparacion de nuevos 6,11-dihidrodibenzo (b,e)-tiepin-11-n-alcohilnorescopin-eteres cuaternarios.
DE3366494D1 (de) New 6-substituted-s-triazolo(3,4-a)phthalazine derivatives
NZ192196A (en) 1-phenyl-2-azolyl-ethanols pharmaceutical compositions
IL64292A (en) D-homoandrostane-17alpha-carboxylic acids,derivatives thereof and 17alpha-spiroethers,their manufacture and pharmaceutical compositions containing them
NZ192195A (en) 1-triazolyl-2-hydroxy-2-phenyl-3-aryl-propanes and pharmaceutical compositions
IT1195051B (it) Composizione di organopolisilossano
ES519690A0 (es) Procedimiento para la obtencion de azolil-fenoxi-tetrahidrofuran-2-iliden-metanos.
BG38638A3 (bg) Метод за получаване на арилциклобутил-аминопроизводни
AU539847B2 (en) 3,4,5-trihydroxypiperidine compounds
RO88069A (ro) Compozitie erbicida de meta-bis-carbanati
SE8404334L (sv) 16-fluoro-16,17-didehydro-prostanoider och forfarande for deras framstellning
ES487362A0 (es) Procedimiento para la preparacion de composiciones mixtas decetoperoxidos
IT7947792A0 (it) Procedimento per la preparazione di n-etiletilendiammina
ES498864A0 (es) Perfeccionamientos en la preparacion de composiciones termo-genas
IT1172263B (it) Procedimento per la preparazione di tio-bisfenoli
IT1169421B (it) Procedimento per la preparazione di benzen-derivati
IT1207205B (it) Procedimento per la preparazione di ciclopropan-nitrili
IT8347549A0 (it) Procedimento per la preparazione di cloroacetanilidi sostituite
IT1197635B (it) Procedimento per la preparazione di 3-idrossi-benzo-diezepinoni
IT1127289B (it) Procedimento per la preparazione di n-cloroimmidi
ES498194A0 (es) Procedimiento para la preparacion de composiciones betu- nes-polimeros
IT1134846B (it) Procedimento per la preparazione di colesterin-derivati
ES267574Y (es) Juego de composicion.
IT8553692V0 (it) Complesso di frammenti predisposti per la composizione di un imitazione di reperto archeologico

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment
B1 Patent granted (law 1993)